Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Hyperhidrosis
Interventions
BIOLOGICAL

Vehicle

Vehicle for ANT-1207 liniment formulation without active ingredient.

BIOLOGICAL

ANT-1207

Botulinum toxin Type A topical liniment (ANT-1207).

Trial Locations (19)

10021

JUVA Skin and Laser Center, New York

14623

Skin Search of Rochester, Inc., Rochester

19046

Allus Clinical Research, Jenkintown

23507

Virginia Clinical Research Inc., Norfolk

27518

PMG Research of Cary, Cary

29414

Dermatology and Laser Center of Charleston, PA, Charleston

33015

San Marcus Research Clinic, Inc., Hialeah

33137

Baumann Cosmetic & Research Institute, Miami

33401

Research Institute of the Southeast, LLC, West Palm Beach

33781

Radiant Research, Inc., Pinellas Park

37215

Tennessee Clinical Research Center, Nashville

37922

The Skin Wellness Center, Knoxville

46032

Shideler Clinical Research Center, Carmel

68144

Skin Specialists, PC, Omaha

70006

William Coleman III, MD, APMC, Metairie

70124

Lupo Center for Aesthetic & General Dermatology, New Orleans

77845

J&S Studies, Inc., College Station

78218

Texas Dermatology and Laser Specialists, San Antonio

78746

Westlake Dermatology Clinical Research Center, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY